Cancer drug prices drop by up to 93%, but 65 costly medicines remain unchanged
- Generic and biosimilar cancer drugs are now up to 93% cheaper under revised government price limits.
- • Prices of 65 costly cancer medicines, including Keytruda, remain unchanged due to limited competition.
- The revised prices for covered medicines will take effect on November 9.
- The government expects the price cap to save patients around ₹2,500 crore annually, but relief will vary by drug.
Source: theprint.in
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
